CompaniesQED Therapeutics
QED Therapeutics logo

QED Therapeutics

active
Palo Alto, CA, United States
Founded 2018
Website
About

Small Molecule Targeting Tyrosine Kinase Receptors

Areas of Focus

Categories

Small Molecule PharmaceuticalBiotech
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

7

By Phase

EARLY_PHASE1: 1

By Status

TERMINATED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
Today
NCT04424966
Hover over trial bars to see details

Recent Trials

NCT04424966Collaborator
Infigratinib in Recurrent High-Grade Glioma Patients
EARLY_PHASE1Terminated
7 participants
Started: Jul 21, 2020 · Completed: Apr 27, 2023
Locations (1)
Headquarters
Palo Alto, CA, United States
Map

Loading map...